Continuous Blood Glucose Monitoring Market Trends, Opportunities, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Continuous Blood Glucose Monitoring Market covers analysis by Component (Insulin Pumps, Sensors, and Transmitters and Receivers); Testing Site (Alternate Site Testing, Finger Tip, and Others); and Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, and Critical Care Patients), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPHE100000865
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.

The mounting inclination of patients towards real-time health monitoring and availability of reliable, frequent, and real time track assistance are the major drivers which are likely to propel the growth of continuous blood glucose monitoring system market. Increase in the prevalence of diabetic patients, rising attention towards health awareness, and increasing affordability of devices are likely to add new opportunities for this market in the coming years.

The "Global Continuous Blood Glucose Monitoring System Market Analysis to 2031" is a specialized and in-depth study of the continuous blood glucose monitoring system industry with a focus on the global market trend. The report aims to provide an overview of global continuous blood glucose monitoring system market with detailed market segmentation by components, testing sites, application, and geography. The global continuous blood glucose monitoring system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The continuous blood glucose monitoring system market is segmented based on components which is further sub- segmented into the insulin pumps, sensors, and transmitters and receivers. The testing site segment is sub divided into alternate site testing, fingertip, and others. Some of the key applications of continuous blood glucose monitoring system are Type 1 diabetic patients, Type 2 diabetic patients, gestational diabetes, and critical care patients, among others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global continuous blood glucose monitoring system market based on components, testing site, and application. It also provides market size and forecast till 2031 for overall continuous blood glucose monitoring system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key continuous blood glucose monitoring system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others.

Continuous Blood Glucose Monitoring Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Component
  • Insulin Pumps
  • Sensors
  • Transmitters and Receivers
By Testing Site
  • Alternate Site Testing
  • Finger Tip
By Application
  • Type 1 Diabetic Patients
  • Type 2 Diabetic Patients
  • Gestational Diabetes
  • Critical Care Patients
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Dexcom, Inc.
  • Abbott
  • Bayer AG
  • F. Hoffmann-La Roche
  • Arkray Inc.
  • Cellnovo
  • Echo Therapeutics Inc.
  • Nemaura
  • Tandem Diabetes Care, Inc.
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Dexcom, Inc.
    2. Abbott
    3. Bayer AG
    4. F. Hoffmann-La Roche
    5. Arkray Inc.
    6. Cellnovo
    7. Echo Therapeutics Inc.
    8. Nemaura
    9. Tandem Diabetes Care, Inc.
    10. PharmaTech Solutions, Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo